What is the price target for IREN stock?
22 analysts have analysed IREN and the average price target is 76.89 USD. This implies a price increase of 143.17% is expected in the next year compared to the current price of 31.62.
NASDAQ:IREN • AU0000185993
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for IREN LTD (IREN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-02-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2026-02-06 | Macquarie | Maintains | Outperform -> Outperform |
| 2026-02-06 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2026-01-13 | HC Wainwright & Co. | Upgrade | Sell -> Buy |
| 2025-12-18 | Goldman Sachs | Initiate | Neutral |
| 2025-11-24 | JP Morgan | Maintains | Underweight -> Underweight |
| 2025-11-19 | Citizens | Initiate | Market Outperform |
| 2025-11-10 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-07 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-11-07 | HC Wainwright & Co. | Maintains | Sell -> Sell |
| 2025-11-03 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-10-29 | HC Wainwright & Co. | Downgrade | Buy -> Sell |
| 2025-10-22 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-10-14 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-10-14 | BTIG | Maintains | Buy -> Buy |
| 2025-09-29 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-09-26 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2025-09-24 | Arete Research | Initiate | Buy |
| 2025-09-23 | Roth Capital | Maintains | Buy -> Buy |
| 2025-09-16 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-09 | BTIG | Maintains | Buy -> Buy |
| 2025-09-02 | Jones Trading | Downgrade | Buy -> Hold |
| 2025-08-29 | Macquarie | Maintains | Outperform -> Outperform |
| 2025-08-29 | Cantor Fitzgerald | Maintains | Overweight -> Overweight |
| 2025-08-29 | B. Riley Securities | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 75.509M 27.90% | 187.192M 147.91% | 501.023M 167.65% | 1.043B 108.17% | 2.885B 176.61% | 4.644B 60.97% | 2.383B -48.69% | 4.364B 83.13% | 7.387B 69.27% | 9.91B 34.15% | |
| EBITDA YoY % growth | N/A -108.49% | N/A 2,356.33% | N/A 254.56% | 512.9M 97.31% | 2.21B 330.88% | 2.751B 24.48% | 1.645B -40.20% | 3.3B 100.61% | 5.917B 79.30% | 8.153B 37.79% | |
| EBIT YoY % growth | -45.441M -2,257.69% | -27.277M 39.97% | 26.514M 197.20% | -201.626M -860.45% | 438.59M 317.53% | 437.82M -0.18% | 708.9M 61.92% | 1.308B 84.51% | 2.227B 70.26% | 3.406B 52.94% | |
| Operating Margin | -60.18% | -14.57% | 5.29% | -19.33% | 15.20% | 9.43% | 29.75% | 29.97% | 30.15% | 34.37% | |
| EPS YoY % growth | -1.16 -733.99% | -0.34 70.62% | 0.64 287.72% | 0.50 -21.87% | -0.55 -209.41% | -0.05 90.52% | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.17 -258.93% | -0.21 -132.56% | -0.24 -121.94% | -0.31 -104.68% | 0.27 253.91% | 0.35 263.00% | 0.84 452.52% | 0.85 377.91% | 1.00 271.49% | 1.00 185.53% |
| Revenue Q2Q % growth | 228.28M 54.14% | 325.72M 73.90% | 526.29M 119.02% | 735.91M 298.45% | 900.08M 294.29% | 984.57M 202.27% | 1.33B 152.71% | 1.463B 98.80% | 1.561B 73.43% | 1.643B 66.87% |
| EBITDA Q2Q % growth | 111.95M 17.50% | 187.2M 72.22% | 365.63M 146.76% | 543.72M 451.96% | 689.59M 515.98% | 756.92M 304.34% | 866.1M 136.88% | 914.37M 68.17% | 1.001B 45.16% | 1.047B 38.32% |
| EBIT Q2Q % growth | -41.232M -247.78% | -26.742M -716.31% | -69.108M -14.92% | -105.904M -25.10% | 123.09M 398.53% | 194.55M 827.52% | 260.18M 476.48% | 265.71M 350.90% | 280.12M 127.57% | 276.41M 42.08% |
All data in USD
22 analysts have analysed IREN and the average price target is 76.89 USD. This implies a price increase of 143.17% is expected in the next year compared to the current price of 31.62.
IREN LTD (IREN) will report earnings on 2026-05-12, after the market close.
The consensus EPS estimate for the next earnings of IREN LTD (IREN) is -0.17 USD and the consensus revenue estimate is 228.28M USD.
The expected long term growth rate for IREN LTD (IREN) is 107.85%.